Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cell2Cure
- Development stage
- Phase 1
- Lead developer
- Cell to Cure
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intralesional
01
Overview
Cell2Cure is an allogeneic cell therapy platform utilizing adipose tissue-derived mesenchymal stromal cells (ASCs). Developed by the Danish biotechnology company Cell2Cure, the therapy (often designated as C2C_ASC) leverages the immunomodulatory, anti-inflammatory, and regenerative properties of MSCs to address a variety of inflammatory and degenerative conditions. The product is derived from healthy donor adipose tissue, expanded in vitro, and administered to patients to promote tissue repair and modulate immune responses. Clinical development is currently focused on indications such as autism spectrum disorder with gastrointestinal symptoms, diabetic foot ulcers, and non-ischemic heart failure, with additional research into lung transplantation complications and ocular diseases.
- Brand names
- Cell2CureCell-2CureCell 2Cure
- Other names
- allogeneic adipose tissue-derived mesenchymal stromal cellsallogeneic adipose-derived mesenchymal stromal cellsASC
Beyond the preview
Go deeper on Cell2Cure.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cell2Cure.